Home » Social Sciences » Call for Papers-Journal of Solid Tumors (JST)

Sponsors

CCSE Journals
Sciedu Press
Macrothink Institute
Redfame Publishing

Call for Papers-Journal of Solid Tumors (JST)

Journal of Solid Tumors publishes research articles and reviews in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of solid tumors, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. Randomized controlled trials, especially phase III trials and evidence-based meta-analysis or pooled analysis related to specific trials are preferred clinical papers. The primary criterion for publication is interest to a multidisciplinary audience.homepageimage_en_us_338

The articles of JST are indexed/reviewed in the following databases/resources:

  • DOAJ
  • EBSCOhost
  • Elsevier
  • Gale’s Academic Databases
  • Google Scholar
  • HINARI
  • Lockss
  • PKP Open Archives Harvester
  • ProQuest

The primary objective of JST is to provide comprehensive coverage and understanding of the cancer biology and medical oncology. JST publishes fully peer-reviewed original basic research articles or clinical research articles in the field of oncology and latest modalities and regimens used to optimize cancer patient outcomes.

We are seeking submissions for forthcoming issue published in June 2013. The paper should be written in professional English. The length of 2000-6000 words is preferred. All manuscripts should be prepared in MS-Word format, and submitted online:http://www.sciedu.ca/jst or sent to: jst@sciedu.ca

To submit original article online for review, you will first need to register with the site as an author. When you log in as an author, you will be guided through the submission process. All submissions must be forwarded electronically to http://www.sciedu.ca/journal/index.php/jst/about/submissions.

It is appreciated if you could share this information with your colleagues and associates. Thank you.